Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00759330 · ClinicalTrials.gov registry record · Phase 2
Flurbiprofen Tape for Treatment of Chronic Low Back Pain
A Phase 2 study, sponsored by Teikoku Pharma USA.
- Completed
- Registry status
- Phase 2
- Development phase
- 127
- Enrollment target
NCT00759330 is a Phase 2 study that has completed, run by Teikoku Pharma USA. The registered enrollment target is 127 participants.
The verdict
NCT00759330, a Phase 2 study, has completed, sponsored by Teikoku Pharma USA.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 127 participants
- Enrollment target
Study Summary
The purpose of this trial is to evaluate the analgesic efficacy and safety of flurbiprofen tape for chronic low back pain (lasting greater than 3 months).
Interventions
- DRUG Placebo Tape (Arm 1)
- DRUG Flurbiprofen Tape (Arm 2)
- DRUG Placebo Tape (Arm 3)
- DRUG Flurbiprofen Tape (Arm 4)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00759330
The ClinicalTrials.gov registry entry for NCT00759330 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Teikoku Pharma USA, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo Tape (Arm 1) is the first listed.
NCT00759330 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00759330 about?
NCT00759330 is a clinical study titled "Flurbiprofen Tape for Treatment of Chronic Low Back Pain". The purpose of this trial is to evaluate the analgesic efficacy and safety of flurbiprofen tape for chronic low back pain (lasting greater than 3 months).
What is the current status of trial NCT00759330?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 127 participants. The study started on 2007-10. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00759330?
The interventions under investigation include: Placebo Tape (Arm 1) (DRUG), Flurbiprofen Tape (Arm 2) (DRUG), Placebo Tape (Arm 3) (DRUG), Flurbiprofen Tape (Arm 4) (DRUG).
Who is sponsoring clinical trial NCT00759330?
This trial is sponsored by Teikoku Pharma USA, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.